Hyperconnectivity in Dementia Is Early and Focal and Wanes with Progression.


Journal

Cerebral cortex (New York, N.Y. : 1991)
ISSN: 1460-2199
Titre abrégé: Cereb Cortex
Pays: United States
ID NLM: 9110718

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 04 05 2020
revised: 19 06 2020
accepted: 08 07 2020
pubmed: 17 8 2020
medline: 31 12 2021
entrez: 16 8 2020
Statut: ppublish

Résumé

We investigated in a longitudinal multicenter cohort study functional cortical connectivity changes along the course of frontotemporal dementia (FTD) and Alzheimer's disease (AD) from the prodromal stage of the diseases. Electroencephalography (EEG) was recorded in 18 FTD and 18 AD patients at the prodromal stage of dementia, at dementia onset, and 3 years after dementia onset. Twenty healthy controls (HC) underwent EEG recordings at the same time interval as the patients. Mutual information (MI) analysis measured the strength of functional network connectivity. FTD and AD patients showed greater MI at the prodromal stage of dementia (FTD vs. HC P = 2 × 10-8; AD vs. HC P = 4 × 10-3). Local connectivity was higher in left and right frontal areas of FTD (P = 7 × 10-5 and 0.03) and in left and right posterior areas in AD (P = 3 × 10-5 and 5 × 10-5) versus HC. We showed cortical hyperconnectivity at the prodromal stage of dementia in areas involved in the specific pathological process of FTD (frontal regions) and AD (posterior regions). Hyperconnectivity disappeared during follow-up, thus suggesting that it is an early electrophysiological feature of dementia, potentially useful to identify prodromal FTD and AD.

Identifiants

pubmed: 32797208
pii: 5892783
doi: 10.1093/cercor/bhaa209
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-105

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Auteurs

Laura Bonanni (L)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Davide Moretti (D)

IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Alzheimer Unit, 25125 Brescia, Italy.

Alberto Benussi (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25040 Brescia, Italy.

Laura Ferri (L)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Mirella Russo (M)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Claudia Carrarini (C)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Filomena Barbone (F)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Dario Arnaldi (D)

Dipartimento di Neuroscienze (DINOGMI), University of Genova, 16132 Genoa, Italy.
U.O. Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Nicola Walter Falasca (NW)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Giacomo Koch (G)

Non Invasive Brain Stimulation Unit/Department of Behavioral and Clinical Neurology, Santa Lucia Foundation IRCCS, 00179 Rome, Italy.

Annachiara Cagnin (A)

Stroke Unit, Department of Neuroscience, Tor Vergata Policlinic, 00184 Rome, Italy.
Department of Neurosciences, University of Padua, 35128 Padova, Italy.

Flavio Nobili (F)

Dipartimento di Neuroscienze (DINOGMI), University of Genova, 16132 Genoa, Italy.
U.O. Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Claudio Babiloni (C)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, 00185 Rome, Italy.
Hospital San Raffaele Cassino (FR), 03043 Cassino, Italy.

Barbara Borroni (B)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25040 Brescia, Italy.

Alessandro Padovani (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25040 Brescia, Italy.

Marco Onofrj (M)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Raffaella Franciotti (R)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, 66100 Chieti, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH